Mapp Biopharmaceutical
Press Inquiries

BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease

May 15, 2024

BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease

October 18, 2022

BARDA partners with Mapp Biopharmaceutical, Inc. to develop next generation therapeutic for Botulinum Neurotoxin

November 24, 2020

PBS NewsHour – How to grow an Ebola vaccine with a tobacco plant

November 23, 2015

ZMapp™ is Granted Orphan Medicinal Product Designation by the EMA

October 15, 2015

ZMapp™ is Granted Fast Track Status by the FDA

September 17, 2015

Monoclonal Antibody-based Filovirus Therapeutic Licensed to Leaf Biopharmaceutical

July 15, 2014

Washington Post – The best innovations of 2014: ZMapp, for offering clues to a potential cure for Ebola

December 22, 2014

Status Update on ZMapp™

October 10, 2014

Consortium Wins Up to $28 Million from NIH to Find Best Proposed Ebola Treatment

March 20, 2014

International Joint Venture to Drive Commercialization of Filovirus Therapeutic via Monoclonal Antibodies

July 29, 2013